End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 SEK | -.--% | -.--% | +3.45% |
07/05 | PEPTONIC medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
17/04 | Peptonic Medical Plans SEK61 Million Shares, Warrants Issue | MT |
Business Summary
Number of employees: 32
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Self-diagnostic Rapid Tests and Self-care Treatments
100.0
%
| 44 | 100.0 % | 37 | 100.0 % | -14.93% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 44 | 100.0 % | 37 | 100.0 % | -14.93% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Erik Sundquist
CEO | Chief Executive Officer | 54 | 14/21/14 |
Albert Lindgren
DFI | Director of Finance/CFO | - | 21/23/21 |
Hadar Kessary
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | 64 | 01/09/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Tarek Shoeb
BRD | Director/Board Member | 55 | 24/23/24 |
Karl Blom
BRD | Director/Board Member | 55 | - |
Anders Norling
BRD | Director/Board Member | 58 | 24/22/24 |
Daniel Rudeklint
BRD | Director/Board Member | 43 | - |
Anna Stinger
BRD | Director/Board Member | - | 24/23/24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,534,845,596 | 114,705,799 ( 7.473 %) | 0 | 7.473 % |
Company contact information
Peptonic Medical AB
Gustavslundsvägen 143
167 51, Bromma
+46 8 53 02 01 10
http://www.peptonicmedical.seSector
1st Jan change | Capi. | |
---|---|---|
+3.45% | 8.52M | |
+5.30% | 109B | |
+11.37% | 105B | |
-0.38% | 22.25B | |
-12.08% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.36% | 16.85B | |
+2.98% | 13.76B | |
+35.85% | 12.46B |
- Stock Market
- Equities
- PMED Stock
- Company PEPTONIC medical AB